Pharmacovigilance (PV) continues to evolve in response to innovation, patient expectations and the globalisation of pharmaceutical operations. As regulatory frameworks such as the upcoming ICH E2D(R3) guideline and emerging market regulations come into effect, organisations must prepare for a new era of safety compliance and audit readiness. These changes aim to make PV more proactive, data-driven and harmonised across regions, but they also demand stronger systems, traceability and governance to withstand inspection.

What’s Changing with ICH E2D(R3)

The revision of ICH E2D focuses on enhancing Post-Approval Safety Data Management, aligning global standards for:

• Integrated safety data collection across digital platforms, real-world evidence, and patient-reported outcomes.
  
• Enhanced risk management throughout a product’s lifecycle.
  
• Improved documentation and data transparency, ensuring consistency between regulatory submissions and safety databases.
  
• Stronger collaboration between sponsors, affiliates, and partners for global reporting.
  

These updates are expected to impact audit frameworks, requiring companies to demonstrate clear traceability of safety data, well-defined governance structures, and accountability across global teams.

Implications for Pharmacovigilance Audits

Audits will increasingly focus on:

• End-to-end data integrity: From signal detection to case processing, ensuring compliant and verifiable data flow.
  
• Cross-border compliance: As companies operate across multiple jurisdictions, auditors will review harmonisation with both ICH and local regulations.
  
• Technology validation: Digital safety platforms, automation, and AI tools must be validated for compliance and audit-ready documentation.
  
• Vendor oversight: Third-party partners managing safety data will need robust quality agreements, governance, and periodic audits.
  

Emerging Market Regulations: Expanding the Audit Horizon

Beyond ICH, several emerging markets, including Latin America, Asia, and the Middle East, are strengthening their local PV frameworks. Each region brings unique expectations on reporting timelines, local case management, and QMS documentation. For multinational organisations, this means audits must now cover global-to-local compliance continuity, ensuring that safety data reported regionally aligns with corporate PV systems. For multinational organisations, this means audits must now cover global-to-local compliance continuity, ensuring that safety data reported regionally aligns with corporate PV systems.

How Q&V Can Support

At Q&V, we help organisations navigate these evolving requirements with confidence.Our expert team provides:

• Comprehensive PV audit and compliance reviews aligned with new global and regional guidelines.
  
• Gap analysis and readiness assessments for ICH E2D(R3) and emerging market PV systems.
  
• Audit preparedness training for internal teams and vendors.
  
• Tailored audit frameworks to ensure ongoing compliance and inspection readiness.
  

By proactively adapting to the next generation of regulations, organisations can not only stay compliant but also strengthen their global safety governance.

Stay audit-ready. Stay compliant. Stay ahead ,with Q&V.